These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24864536)

  • 1. Old drug in new package promises to calm the agitated.
    Morrow T
    Manag Care; 2014 Apr; 23(4):50-1. PubMed ID: 24864536
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy review of inhaled loxapine for treatment of agitation.
    Currier G; Walsh P
    Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):25-32. PubMed ID: 23538290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Vieta E
    BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.
    Owen RT
    Drugs Today (Barc); 2013 Mar; 49(3):195-201. PubMed ID: 23527323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia.
    Keating GM
    CNS Drugs; 2013 Jun; 27(6):479-89. PubMed ID: 23740380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New medical approach to out-of-hospital treatment of psychomotor agitation in psychiatric patients: a report of 14 cases].
    Cester-Martínez A; Cortés-Ramas JA; Borraz-Clares D; Pellicer-Gayarre M
    Emergencias; 2017 Jun; 29(3):182-184. PubMed ID: 28825239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled loxapine for the urgent treatment of acute agitation associated with schizophrenia or bipolar disorder.
    Pollack CV
    Curr Med Res Opin; 2016 Jul; 32(7):1253-60. PubMed ID: 27121764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2011 Mar; 65(3):330-40. PubMed ID: 21199198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the medicine administration route on health-related quality of life: Results from a time trade-off survey in patients with bipolar disorder or schizophrenia in 2 Nordic countries.
    Jørgensen TR; Emborg C; Dahlen K; Bøgelund M; Carlborg A
    BMC Psychiatry; 2016 Jul; 16():244. PubMed ID: 27421880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change.
    Pacciardi B; Calcedo A; Messer T
    Drugs R D; 2019 Mar; 19(1):15-25. PubMed ID: 30721526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Now take a deep breath: inhaled loxapine for the treatment of acute agitation.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Jan; 50(1):16-8. PubMed ID: 22229963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhalative loxapine: old tried and trusted medication with new indications].
    Juckel G
    Nervenarzt; 2013 Sep; 84(9):1113-4, 1116. PubMed ID: 23846335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.
    Kwentus J; Riesenberg RA; Marandi M; Manning RA; Allen MH; Fishman RS; Spyker DA; Kehne JH; Cassella JV
    Bipolar Disord; 2012 Feb; 14(1):31-40. PubMed ID: 22329470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Montañés F; Dobrovolskaya N; Bukhanovskaya O; Popov M; Vieta E
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):710-718. PubMed ID: 29724638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
    J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled Loxapine for ECT Pretreatment for Agitation.
    Jaffe R; Siniscalchi M; Cruz-Luna N; Cosgrove D
    J ECT; 2016 Jun; 32(2):146. PubMed ID: 26439438
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial.
    Gil E; Garcia-Alonso F; Boldeanu A; Baleeiro Teixeira T;
    BMJ Open; 2018 Oct; 8(10):e020242. PubMed ID: 30282677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Inhaled Loxapine in Dual-Diagnosis Patients: A Case Series.
    Roncero C; Ros-Cucurull E; Grau-López L; Fadeuilhe C; Casas M
    Clin Neuropharmacol; 2016; 39(4):206-9. PubMed ID: 27015036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Management of Psychomotor Agitation Associated with Schizophrenia or Bipolar Disorder: A Brief Review.
    Pompili M; Ducci G; Galluzzo A; Rosso G; Palumbo C; De Berardis D
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33924111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.